Association Between Drug-related Cutaneous Adverse Events and Progression Free Survival in Patients Treated with Enfortumab Vedotin

Clinical trial NCT06682845 · COMPLETED

Trial details

NCT number: NCT06682845
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Study type: OBSERVATIONAL

Cutaneous Adverse

Start date: 2024-05-02
Primary completion: 2024-05-02
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.